SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-011398
Filing Date
2020-06-18
Accepted
2020-06-18 16:29:56
Documents
1
Period of Report
2020-06-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1494
  Complete submission text file 0001493152-20-011398.txt   3122
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
OncBioMune Pharmaceuticals, Inc (Issuer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1601 BLAKE ST. SUITE 310 DENVER CO 80202
Business Address
Busch Jeffrey (Reporting) CIK: 0001620772 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52218 | Film No.: 20972939